Get started

Buy

GBP/CHF LONG FROM SUPPORT Hello, Friends! GBP/CHF pair is in the downtrend because previous week’s candle is red, while the price is obviously falling on the 1D timeframe. And after the retest of the support line below I believe we will see a move up towards the target above at 1.116 because the pair oversold due to its proximity to the lower BB band and a bullish correction is likely. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. ✅LIKE AND COMMENT MY IDEAS✅
Long
by EliteTradingSignals
1
US30 Will Move Higher! Buy! Take a look at our analysis for US30. Time Frame: 1h Current Trend: Bullish Sentiment: Oversold (based on 7-period RSI) Forecast: Bullish The market is testing a major horizontal structure 44,556.0. Taking into consideration the structure & trend analysis, I believe that the market will reach 44,867.4 level soon. P.S Please, note that an oversold/overbought condition can last for a long time, and therefore being oversold/overbought doesn't mean a price rally will come soon, or at all. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. Like and subscribe and comment my ideas if you enjoy them!
TRADENATION:US30Long
by SignalProvider
1
EURNZD Is Bullish! Long! Please, check our technical outlook for EURNZD. Time Frame: 9h Current Trend: Bullish Sentiment: Oversold (based on 7-period RSI) Forecast: Bullish The market is approaching a key horizontal level 1.944. Considering the today's price action, probabilities will be high to see a movement to 1.965. P.S The term oversold refers to a condition where an asset has traded lower in price and has the potential for a price bounce. Overbought refers to market scenarios where the instrument is traded considerably higher than its fair value. Overvaluation is caused by market sentiments when there is positive news. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. Like and subscribe and comment my ideas if you enjoy them!
Long
by SignalProvider
5
SWING IDEA - AJANTA PHARMAAjanta Pharma , a mid-cap pharma player with strong branded generics in ophthalmology, dermatology, and cardiology, is showing a compelling swing trade setup backed by a high-probability technical breakout. Reasons are listed below : Bullish engulfing candle on the weekly timeframe, indicating reversal strength 2,500 zone acting as a crucial support Holding above 0.382 Fibonacci retracement level , suggesting healthy correction Price trading above 50 & 200 EMA on the weekly chart – long-term strength intact Breakout from narrow consolidation near the 50-week EMA Target - 3080 // 3400 Stoploss - weekly close below 2415 DISCLAIMER - Decisions to buy, sell, hold or trade in securities, commodities and other investments involve risk and are best made based on the advice of qualified financial professionals. Any trading in securities or other investments involves a risk of substantial losses. The practice of "Day Trading" involves particularly high risks and can cause you to lose substantial sums of money. Before undertaking any trading program, you should consult a qualified financial professional. Please consider carefully whether such trading is suitable for you in light of your financial condition and ability to bear financial risks. Under no circumstances shall we be liable for any loss or damage you or anyone else incurs as a result of any trading or investment activity that you or anyone else engages in based on any information or material you receive through TradingView or our services. @visionary.growth.insights
NSE:AJANTPHARMLong
by Visionary_Growth_Insights
USDJPY Is Very Bullish! Buy! Here is our detailed technical review for USDJPY. Time Frame: 1D Current Trend: Bullish Sentiment: Oversold (based on 7-period RSI) Forecast: Bullish The market is approaching a significant support area 144.493. The underlined horizontal cluster clearly indicates a highly probable bullish movement with target 148.651 level. P.S Overbought describes a period of time where there has been a significant and consistent upward move in price over a period of time without much pullback. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. Like and subscribe and comment my ideas if you enjoy them!
Long
by SignalProvider
1
CADCHF Is Going Up! Long! Take a look at our analysis for CADCHF. Time Frame: 1h Current Trend: Bullish Sentiment: Oversold (based on 7-period RSI) Forecast: Bullish The market is on a crucial zone of demand 0.583. The oversold market condition in a combination with key structure gives us a relatively strong bullish signal with goal 0.585 level. P.S Please, note that an oversold/overbought condition can last for a long time, and therefore being oversold/overbought doesn't mean a price rally will come soon, or at all. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. Like and subscribe and comment my ideas if you enjoy them!
Long
by SignalProvider
1
Gold Price Maintains Bullish MomentumGold is currently trading within a converging wedge pattern, following a strong rebound from the recent bottom near 3,210 USD. If price holds above the 3,276 USD support zone and shows bullish confirmation, the next target will be a breakout above the descending trendline, aiming for the 3,359 USD resistance zone — a key level to confirm the continuation of the uptrend. From a fundamental perspective, the weakening USD — driven by expectations of cautious Fed rate cuts — combined with lingering geopolitical risks and strong central bank demand (over 1,000 tons annually), continues to provide solid support for gold. Overall Trend: Bullish Confirmation Condition: Price holds above 3,276 USD and breaks the upper wedge Mid-term Target: 3,359 to 3,400 USD
OANDA:XAUUSDLong
by Rocky_trade_
GBPJPY Will Go Up! Buy! Please, check our technical outlook for GBPJPY. Time Frame: 3h Current Trend: Bullish Sentiment: Oversold (based on 7-period RSI) Forecast: Bullish The market is approaching a key horizontal level 197.240. Considering the today's price action, probabilities will be high to see a movement to 198.091. P.S Please, note that an oversold/overbought condition can last for a long time, and therefore being oversold/overbought doesn't mean a price rally will come soon, or at all. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. Like and subscribe and comment my ideas if you enjoy them!
Long
by SignalProvider
3
USD/CHF BULLS WILL DOMINATE THE MARKET|LONG Hello, Friends! Bullish trend on USD/CHF, defined by the green colour of the last week candle combined with the fact the pair is oversold based on the BB lower band proximity, makes me expect a bullish rebound from the support line below and a retest of the local target above at 0.828. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. ✅LIKE AND COMMENT MY IDEAS✅
Long
by EliteTradingSignals
1
VKTX: Unusual Options Flow & a Breakthrough Weight-Loss DrugIf you haven`t bought CKTX before the recent rally: Now you need to know that Viking Therapeutics (VKTX) is a speculative biotech stock in the GLP-1/GIP agonist space, aiming to challenge market leaders like Eli Lilly and Novo Nordisk. Recently, I noticed unusual options flow — specifically, Jan 16, 2026 $60 strike calls Key Bullish Points 1) Riding the Obesity Drug Boom VK2735 is Viking’s dual agonist candidate showing promising early weight-loss efficacy, with potential overlap benefits in NASH (liver disease). The obesity treatment space is expected to exceed $100B by 2030—huge upside if their trials continue positively. 2) Options Flow Tells a Story Those Jan 2026 $60 calls caught my attention precisely because the stock currently trades in the mid-$60s. These aren’t cheap lottery plays—they’re strategically timed wrt trial readouts, partnerships, or acquisition interest. Essentially, someone anticipates meaningful upside in the near future. 3) Descending Wedge — Chart Looks Bullish VKTX peaked near $100, then pulled back into a well-defined descending wedge. If it breaks out above $70–$72 with volume, that could kick off a classic reversal trade. Smart Money Options Flow — Near-Term Bet: Recently, I spotted unusual open interest in $60 strike calls expiring Jan 16, 2026 — that’s only about 7 months away. This means someone is positioning for a big upside move relatively soon, likely betting on positive Phase 2b/3 data, a partnership deal, or even buyout chatter within the next few quarters. Short-dated, out-of-the-money call flow like this often hints at near-term news — not just a long-dated hedge.
NASDAQ:VKTXLong
by TopgOptions
KWEB: China’s Internet Sector - AI Catch-Up and Cheap ValuationsChina’s internet and tech stocks have been hammered for years — regulatory crackdowns, slowing growth fears, and geopolitical tension have crushed sentiment. But as investors know, the best opportunities often hide in what everyone hates. Enter KWEB, the KraneShares CSI China Internet ETF. It’s a diversified, liquid way to play a bounce in major names like Alibaba, Tencent, JD .com, Baidu, Meituan and PDD. Here’s why I think the risk/reward looks compelling now — especially if you believe in AI closing the gap. Key Bullish Points: 1) Valuations at Rock-Bottom Many big China internet stocks are still trading at single-digit P/E ratios, even as their cash flows recover. Compared to U.S. big tech trading at 30–50x, this is a huge valuation gap. Regulatory fears seem largely priced in — Beijing wants growth, not stagnation, and some policies are easing. 2) China’s AI Push — Just “Months Behind” Jansen Whang recently argued that China’s generative AI development is only “months behind” the U.S. Players like Baidu, Alibaba Cloud, Tencent, and SenseTime are all racing to launch new LLMs and integrated AI tools. If you believe the gap closes, Chinese platforms could see a major earnings rebound as they roll out AI upgrades across search, cloud, e-commerce and social media. 3) Sentiment So Bad, It’s Good When the headlines scream “China is uninvestable,” that’s often when big mean reversion trades set up. Even a small policy pivot, stimulus plan, or positive AI news cycle can spark a sharp rally. KWEB is one of the cleanest ways to express this view because it holds a diversified basket — you don’t have to pick a single winner.
AMEX:KWEBLong
by TopgOptions
LCID: Could a Saudi Buyout Send This EV Stock Back to $10?If you haven`t sold LCID before the previous earnings: Now you need to know that Lucid Motors (LCID) is one of the most polarizing EV stocks in the market — but it’s also one of the most interesting speculative turnarounds. Yes, the company faces production challenges, cash burn, and fierce competition from Tesla, BYD, and legacy automakers. But it has some unique wildcards that most other EV startups don’t: 1) The “Musk Factor” Musk’s public comments about Lucid being “basically controlled by the Saudis” and that they make better-looking cars than Tesla might sound like trolling, but they highlight a real truth: Lucid isn’t just another budget EV player — it’s positioned as a luxury rival with design appeal that matters to high-end buyers. 2) Saudi PIF Is Deep In — Valuation Floor The Saudi sovereign wealth fund has put billions into LCID already — and now owns around 60%+ of the shares. They’ve made no secret of their plans to expand the kingdom’s domestic EV production and see Lucid as a flagship partner. Rumors have swirled for years about a possible full buyout to bring Lucid fully under the PIF umbrella — or merge it with other Middle East EV initiatives like the Ceer brand. Any credible news here could double or triple the stock overnight from these depressed levels. 3) Gravity SUV & Product Pipeline The Lucid Air remains one of the few luxury EVs that truly competes with Tesla’s Model S in both design and range. The upcoming Gravity SUV could be the next big catalyst, especially as the luxury SUV segment has fatter margins and huge global demand. Meanwhile, the new AMP-2 factory in Saudi Arabia will help Lucid localize production, get tax incentives, and serve the Middle East and Europe more cost-effectively. 4) Technical Setup: Double Bottom Pattern Here’s what really makes this setup tradable: LCID is showing a clear double bottom on the daily chart around the $2–$2.20 zone. The stock tested that level twice and bounced, forming a W-shaped base that can signal a reversal. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:LCIDLong
by TopgOptions
1
Why IonQ (IONQ) Could Be the NVDA of Quantum ComputingIf you haven`t bought IONQ before the rally: Now you need to know that IonQ isn’t just another speculative quantum stock — The company is building a robust ecosystem around its best‑in‑class trapped‑ion architecture and targeting fault‑tolerant, networked quantum systems. With record bookings, major acquisitions, and a strong balance sheet, IonQ could emerge as the NVIDIA equivalent for quantum infrastructure. Key Bullish Arguments 1) Superior Quantum Tech – Trapped‑Ion Advantage IonQ’s trapped-ion processors boast 99.9% two-qubit fidelity, demonstrating higher accuracy and scalability than superconducting alternatives These systems also operate at room temperature, meaning simpler deployment and lower costs 2) Ecosystem Strategy & Acquisitions The $1.08B acquisition of Oxford Ionics (expected close in 2025) expands IonQ’s qubit control tech, pushing toward planned 80,000 logical‑qubit systems by decade’s end Combined with ID Quantique and Lightsynq, IonQ is building a full-stack quantum and networking offering 3) Strong Revenue Growth & Cash Runway Revenue soared from $22M in 2023 to $43.1M in 2024, with bookings of $95.6M . Q1 2025 saw $7.6M revenue and EPS –$0.14, beating expectations; cash reserves near $697M provide years of runway 4) Real Commercial Deployments IonQ sold its Forte Enterprise quantum system to EPB ($22M deal) for hybrid compute and networking, marking real-world commercial applications 5) AI & Quantum Synergy Involvement in NVIDIA’s Quantum Day and hybrid quantum‑classical AI demos (e.g., blood pump simulation with Ansys, ~12 % faster) indicates strategic synergy and positions IonQ as a critical piece in the future AI stack Recent Catalysts: Texas Quantum Initiative passes – positions IonQ at forefront of U.S. state-backed innovation Oxford Ionics acquisition pending – major expansion in qubit scale & tech Barron’s analyst buys – industry analysts see long-term potential; IonQ among top quantum picks Broader quantum optimism – McKinsey & Morgan Stanley forecasts highlight synergy between quantum and AI, benefiting IonQ
NYSE:IONQLong
by TopgOptions
Why Palantir (PLTR) Could Be the NVDA of Government AI If you haven`t bought PLTR before the massive rally: Palantir Technologies (PLTR) is proving it’s more than just another AI hype play — it’s becoming a core piece of the secure AI infrastructure for governments and large enterprises worldwide. Key Bullish Arguments 1) Strong Government Moat PLTR’s deep relationship with the U.S. government, NATO, and allies provides sticky, long-term revenue streams. In an age of geopolitical tension, this is exactly the type of mission-critical AI spending that stays funded. 2) Expanding Commercial Footprint The commercial segment is no longer a side project. Palantir’s Foundry and Apollo platforms help enterprises deploy AI at scale — securely, in-house, and without sending sensitive data to open systems. Recent deals in healthcare, energy, and critical infrastructure show they’re broadening their customer base. 3) Profitability & Balance Sheet Palantir is GAAP profitable for six consecutive quarters, with strong free cash flow and zero debt. For a growth stock in AI, this gives it rare staying power if macro conditions tighten. 4) Technical Strength The stock broke out above ~$125–$130 support and is now testing key resistance in the $140–$148 range. Weekly momentum remains bullish, and institutional accumulation (A/D line) remains strong. 5) AI Tailwinds Remain While the general AI trade has cooled for some names, PLTR’s unique moat in secure and domain-specific AI makes it more defensible than generic “AI SaaS” stocks. New contracts or AI platform updates could reignite momentum this summer. Possible Summer Catalysts New multi-year government deals — especially in defense and cybersecurity. Major commercial partnerships — especially in healthcare or energy. AI platform upgrades — more integrations with LLMs or domain-specific AI. Inclusion in AI-focused ETFs — or further index rebalancing inflows. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
TRADENATION:PLTRLong
by TopgOptions
CRSP Could Crack the Holy Grails of Medicine: Cancer & AlzheimerWhen Tesla (TSLA) started, few believed a scrappy EV startup could transform the entire auto industry and ignite a green energy revolution. But it did. Today, CRISPR Therapeutics (NASDAQ: CRSP) is quietly doing something similar for medicine — and if you squint, its upside might be even bigger than Tesla’s. Gene Editing: The Next Industrial Revolution — For Your Cells CRISPR/Cas9 gene editing is like biological software. It gives scientists the power to cut, delete, or rewrite genes — the source code of life — with surgical precision. CRISPR Therapeutics was co-founded by Dr. Emmanuelle Charpentier, a Nobel Prize winner who helped pioneer this breakthrough. The company’s lead therapy, exa-cel — just FDA approved in the U.S. — is the first-ever CRISPR-based gene-editing treatment to hit the market. First up: curing devastating blood disorders like sickle cell disease and beta-thalassemia — a $10 billion+ opportunity. But that’s only the start. Aging: The Ultimate Disease What if we treated aging itself as a disease? Many scientists now argue that growing old is the result of accumulated genetic errors, cellular damage, and mutations — processes that can be slowed or even reversed. Gene editing holds the promise to repair DNA damage, reprogram cells, and treat the root causes of age-related decline. If successful, it could extend healthy human lifespan by decades. Think about that: Tesla made cars last longer and burn cleaner. CRSP could make you last longer and live healthier. The Two Holy Grails: Cancer and Alzheimer’s Beyond blood disorders, CRISPR Therapeutics is working on a pipeline targeting solid tumors, diabetes, and more. But the real game-changers are cancer and Alzheimer’s disease — the twin mountains every biotech company dreams of conquering. With gene editing, we could one day rewrite the genetic mutations that fuel cancer growth or remove the faulty proteins that clog the brain in Alzheimer’s. These are trillion-dollar problems — and the company that cracks them will reshape human history. Built for Scale — Like Tesla CRSP isn’t going at it alone. Partnerships with Vertex, Bayer, and ViaCyte help spread risk and amplify impact. With over $2 billion in cash, it has the runway to execute — just as Tesla used capital to build factories and charging networks at scale. The market still underestimates that this is a platform company — not a single-drug biotech. If Tesla went from cars to batteries, solar, and AI, CRSP could go from blood disorders to rewriting the code for life itself. Bottom Line Aging. Cancer. Alzheimer’s. These are the holy grails of medicine. If you missed Tesla at $20 a share, CRISPR Therapeutics could be your second chance — the TSLA of Gene Editing. Because the greatest disruption of all is not electric cars. It’s the chance that, one day, growing old will be optional.
NASDAQ:CRSPLong
by TopgOptions
5
GOLD Will Move Higher! Long! Here is our detailed technical review for GOLD. Time Frame: 9h Current Trend: Bullish Sentiment: Oversold (based on 7-period RSI) Forecast: Bullish The market is approaching a significant support area 3,347.97. The underlined horizontal cluster clearly indicates a highly probable bullish movement with target 3,408.78 level. P.S The term oversold refers to a condition where an asset has traded lower in price and has the potential for a price bounce. Overbought refers to market scenarios where the instrument is traded considerably higher than its fair value. Overvaluation is caused by market sentiments when there is positive news. Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis. Like and subscribe and comment my ideas if you enjoy them!
TRADENATION:XAUUSDLong
by SignalProvider
1